Akari Therapeutics (AKTX) Equity Ratio (2011 - 2026)
Akari Therapeutics recorded quarterly Equity Ratio of 0.42 in Q1 2026, down 28.26% quarter-over-quarter from 0.59 in Q4 2025, and down 0.56% year-over-year from 0.43 in Q1 2025.
Akari Therapeutics' Equity Ratio history runs 16 years deep, the most recent figure standing at 0.42 for Q1 2026.
- In Q1 2026, Equity Ratio fell 0.56% year-over-year to 0.42; the TTM figure through Mar 2026 stood at 0.42 (down 0.56% YoY), while the FY2025 annual figure was 0.59, up 34.54% from the prior year.
- Equity Ratio came in at 0.42 for Q1 2026 at Akari Therapeutics, down from 0.59 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.73 in Q2 2022 to a low of 2.45 in Q3 2024.
- A 5-year average of 0.02 and a median of 0.43 in 2025 frame the typical range for Equity Ratio.
- Across the five-year window, Equity Ratio soared 89602.95% in 2022 and plunged 310.2% in 2024, its largest moves.
- Akari Therapeutics' Equity Ratio stood at 0.13 in 2022, then plunged by 140.61% to 0.05 in 2023, then surged by 936.08% to 0.44 in 2024, then surged by 34.54% to 0.59 in 2025, then retreated by 28.26% to 0.42 in 2026.
- According to Business Quant data, Equity Ratio over the past three periods registered 0.42, 0.59, and 0.5 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.21 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 0.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.42 |
| Dec 31, 2025 | 0.59 |
| Sep 30, 2025 | 0.50 |
| Jun 30, 2025 | 0.50 |
| Mar 31, 2025 | 0.43 |
| Dec 31, 2024 | 0.44 |
| Sep 30, 2024 | -2.45 |
| Jun 30, 2024 | -0.73 |
| Mar 31, 2024 | -1.28 |
| Dec 31, 2023 | -0.05 |
| Jun 30, 2023 | 0.35 |
| Dec 31, 2022 | 0.13 |
| Jun 30, 2022 | 0.73 |
| Mar 31, 2022 | 0.72 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.77 |
| Jun 30, 2021 | 0.33 |
| Mar 31, 2021 | 0.50 |
| Sep 30, 2020 | 0.51 |
| Jun 30, 2020 | 0.41 |
| Mar 31, 2020 | 0.34 |
| Dec 31, 2019 | 0.22 |
| Sep 30, 2019 | 0.48 |
| Jun 30, 2019 | 0.10 |
| Mar 31, 2019 | 0.59 |
| Dec 31, 2018 | 0.00 |
| Sep 30, 2018 | 10.21 |
| Jun 30, 2018 | 1.34 |
| Mar 31, 2018 | -0.01 |
| Dec 31, 2017 | 0.00 |
| Sep 30, 2017 | 0.58 |
| Jun 30, 2017 | 0.71 |
| Mar 31, 2017 | 0.61 |
| Dec 31, 2016 | 0.00 |
| Sep 30, 2016 | 0.79 |
| Jun 30, 2016 | 0.70 |
| Mar 31, 2016 | 0.74 |
| Dec 31, 2015 | 0.00 |
| Sep 30, 2015 | 0.52 |
| Jun 30, 2015 | 0.33 |
| Mar 31, 2015 | 0.60 |
| Dec 31, 2014 | 0.65 |
| Dec 31, 2013 | 0.05 |
| Dec 31, 2012 | -3.00 |
| Dec 31, 2011 | -92.04 |